0001411617-22-000001.txt : 20220908 0001411617-22-000001.hdr.sgml : 20220908 20220908170715 ACCESSION NUMBER: 0001411617-22-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20220908 DATE AS OF CHANGE: 20220908 EFFECTIVENESS DATE: 20220908 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Diasome Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001411617 IRS NUMBER: 263050656 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-458372 FILM NUMBER: 221234426 BUSINESS ADDRESS: STREET 1: 10000 CEDAR AVENUE STREET 2: SUITE 6 CITY: CLEVELAND STATE: OH ZIP: 44106 BUSINESS PHONE: 216-444-7110 MAIL ADDRESS: STREET 1: 10000 CEDAR AVENUE STREET 2: SUITE 6 CITY: CLEVELAND STATE: OH ZIP: 44106 FORMER COMPANY: FORMER CONFORMED NAME: Diasome Pharmaceuticals INC DATE OF NAME CHANGE: 20170113 FORMER COMPANY: FORMER CONFORMED NAME: Diasome Pharmaceuticals LLC DATE OF NAME CHANGE: 20070906 D 1 primary_doc.xml X0708 D LIVE 0001411617 Diasome Pharmaceuticals, Inc. 10000 CEDAR AVENUE SUITE 6 CLEVELAND OH OHIO 44106 216-444-7110 DELAWARE Diasome Pharmaceuticals INC Diasome Pharmaceuticals LLC Corporation true Robert Geho c/o Diasome Pharmaceuticals, Inc. 10000 Cedar Avenue, Suite 6 Cleveland OH OHIO 44106 Executive Officer Director Promoter W. Blair Geho c/o Diasome Pharmaceuticals, Inc. 10000 Cedar Avenue, Suite 6 Cleveland OH OHIO 44106 Director Thomas McDonald c/o Diasome Pharmaceuticals, Inc. 10000 Cedar Avenue, Suite 6 Cleveland OH OHIO 44106 Director Frank McCaney c/o Diasome Pharmaceuticals, Inc. 10000 Cedar Avenue, Suite 6 Cleveland OH OHIO 44106 Director Marc Penn c/o Diasome Pharmaceuticals, Inc. 10000 Cedar Avenue, Suite 6 Cleveland OH OHIO 44106 Director Biotechnology Decline to Disclose 06b false 2022-08-26 false true false 0 19092510 16724591 2367919 The Total Offering Amount and Total Amount Sold include convertible debt and the securities issuable hereto. false 40 0 537746 0 false Diasome Pharmaceuticals, Inc. /s/ Robert Geho Robert Geho Chief Executive Officer 2022-09-08